StockData
Ironwood Pharmaceuticals Inc logo

Ironwood Pharmaceuticals Inc (IRWD) stock

IRWDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3062% below fair value
$4.87+0.02 (+0.41%)

Close on Nov 17, 2026Market cap $804.72MP/E 6.3Yield –

Ironwood Pharmaceuticals cash

Cash and short-term investments held at the end of each period.

Ironwood Pharmaceuticals's cash was $79.13M at Jun 30, 2026. For fiscal 2025 it was $215.46M, up 143.3% from the year before. Over ten years it grew -2.2% a year on average. The highest annual figure on record is $656.20M in fiscal 2022.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$215.46M+143.3%
FY2024Dec 31, 2024$88.56M-3.9%
FY2023Dec 31, 2023$92.15M-86.0%
FY2022Dec 31, 2022$656.20M+5.5%
FY2021Dec 31, 2021$621.86M+70.5%
FY2020Dec 31, 2020$364.78M+103.5%
FY2019Dec 31, 2019$179.24M-0.9%
FY2018Dec 31, 2018$180.85M-20.8%
FY2017Dec 31, 2017$228.47M+267.0%
FY2016Dec 31, 2016$62.25M-76.9%
FY2015Dec 31, 2015$270.03M+263.5%
FY2014Dec 31, 2014$74.30M-1.6%
FY2013Dec 31, 2013$75.49M-44.8%
FY2012Dec 31, 2012$136.70M+56.6%
FY2011Dec 31, 2011$87.28M+96.9%
FY2010Dec 31, 2010$44.32M-63.8%
FY2009Dec 31, 2009$122.31M+84.4%
FY2008Dec 31, 2008$66.33M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$79.13M-14.8%
Q1 FY2026Mar 31, 2026$220.47M+103.2%
Q4 FY2025Dec 31, 2025$215.46M+143.3%
Q3 FY2025Sep 30, 2025$140.41M+59.2%
Q2 FY2025Jun 30, 2025$92.85M-12.0%
Q1 FY2025Mar 31, 2025$108.48M-10.7%
Q4 FY2024Dec 31, 2024$88.56M-3.9%
Q3 FY2024Sep 30, 2024$88.21M-19.9%
Q2 FY2024Jun 30, 2024$105.52M-39.8%
Q1 FY2024Mar 31, 2024$121.54M-83.6%
Q4 FY2023Dec 31, 2023$92.15M-86.0%
Q3 FY2023Sep 30, 2023$110.16M-80.8%
Q2 FY2023Jun 30, 2023$175.32M-65.2%
Q1 FY2023Mar 31, 2023$740.34M+24.8%
Q4 FY2022Dec 31, 2022$656.20M+5.5%
Q3 FY2022Sep 30, 2022$574.19M-0.0%
Q2 FY2022Jun 30, 2022$504.37M+2.4%
Q1 FY2022Mar 31, 2022$593.37M+35.3%
Q4 FY2021Dec 31, 2021$621.86M+70.5%
Q3 FY2021Sep 30, 2021$574.28M+86.7%
Q2 FY2021Jun 30, 2021$492.70M+94.5%
Q1 FY2021Mar 31, 2021$438.47M+89.7%
Q4 FY2020Dec 31, 2020$364.78M+103.5%
Q3 FY2020Sep 30, 2020$307.56M+120.9%
Q2 FY2020Jun 30, 2020$253.25M+156.0%
Q1 FY2020Mar 31, 2020$231.14M+94.2%
Q4 FY2019Dec 31, 2019$179.24M-0.9%
Q3 FY2019Sep 30, 2019$139.23M-13.7%
Q2 FY2019Jun 30, 2019$98.91M-45.4%
Q1 FY2019Mar 31, 2019$119.05M-38.8%
Q4 FY2018Dec 31, 2018$180.85M-20.8%
Q3 FY2018Sep 30, 2018$161.40M-0.8%
Q2 FY2018Jun 30, 2018$181.25M-0.5%
Q1 FY2018Mar 31, 2018$194.45M+45.9%
Q4 FY2017Dec 31, 2017$228.47M+267.0%
Q3 FY2017Sep 30, 2017$162.64M-11.1%
Q2 FY2017Jun 30, 2017$182.13M–
Q1 FY2017Mar 31, 2017$133.32M–
Q4 FY2016Dec 31, 2016$62.25M–
Q3 FY2016Sep 30, 2016$182.94M–

More Ironwood Pharmaceuticals figures

See a number that looks wrong?